Back to Search Start Over

The crosstalk of Wnt/β-catenin signaling and p53 in acute kidney injury and chronic kidney disease.

Authors :
Ming WH
Wen L
Hu WJ
Qiao RF
Zhou Y
Su BW
Bao YN
Gao P
Luan ZL
Source :
Kidney research and clinical practice [Kidney Res Clin Pract] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Wnt/β-catenin is a signaling pathway associated with embryonic development, organ formation, cancer, and fibrosis. Its activation can repair kidney damage during acute kidney injury (AKI) and accelerate the occurrence of renal fibrosis after chronic kidney disease (CKD). Interestingly, p53 has also been found as a key modulator in AKI and CKD in recent years. Meantime, some studies have found crosstalk between Wnt/β-catenin signaling pathways and p53, but more evidence is required on whether they have synergistic effects in renal disease progression. This article reviews the role and therapeutic targets of Wnt/β-catenin and p53 in AKI and CKD and proposes for the first time that Wnt/β-catenin and p53 have a synergistic effect in the treatment of renal injury.

Details

Language :
English
ISSN :
2211-9132
Database :
MEDLINE
Journal :
Kidney research and clinical practice
Publication Type :
Academic Journal
Accession number :
39558651
Full Text :
https://doi.org/10.23876/j.krcp.23.344